RA
ITRI icon

Royce & Associates’s Itron ITRI Stock Holding History

Royce & Associates’s Portfolio ITRI Stock Details ITRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Buy
19,693
+9,149
+87% +$781K 0.01% 635
2026
Q1 		$945K Buy
10,544
+2,476
+31% +$238K 0.01% 650
2025
Q4 		$749K Buy
8,068
+1,100
+16% +$120K 0.01% 679
2025
Q3 		$868K Hold
6,968
– – 0.01% 678
2025
Q2 		$917K Buy
6,968
+2,696
+63% +$305K 0.01% 674
2025
Q1 		$448K Buy
+4,272
New +$447K ﹤0.01% 737

Other funds holding ITRI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Royce & Associates's ITRI Position: Q2 2026 in Review

Royce & Associates increased its Itron (ITRI) stake by 87% in Q2 2026, buying an estimated $781K and bringing the position to 19,693 shares worth $1.7M. The position accounts for 0.01% of the portfolio, ranked #635.

Royce & Associates first reported a position in ITRI in Q1 2025 and has held it in 6 quarters since. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Royce & Associates held 19,693 shares of Itron worth $1.7M as of Q2 2026.
  • Royce & Associates bought 9,149 Itron shares in Q2 2026, an estimated $781K.
  • Itron made up 0.01% of Royce & Associates's portfolio in Q2 2026, its #635 holding.
  • Royce & Associates first reported a position in Itron in Q1 2025 and has held it in 6 quarters since.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.